🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy

PLoS Pathogens(2022)10.1371/journal.ppat.1010248Source: DataRank Database

A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy is a research paper published in PLoS Pathogens (2022). On theSindex it has a DataRank of 0. It has been cited 80 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access80 citations

Cite:

Linked data & code

bioproject gen gisaid pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 6.96)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (5)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Tyler N. Starr ORCID,Rachel Eguia ORCID,Andrea N. Loes ORCID,Khadija Khan ORCID,Farina Karim ORCID

Live enrichment

PubMed:35134084 PMC:PMC8856557 OpenAlex:https://openalex.org/W4220761771

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201400006C

National Institute of Allergy and Infectious Diseases

Grant: 75N93021C00015

National Institute of Allergy and Infectious Diseases

Grant: R01AI141707

National Institute of Allergy and Infectious Diseases

Grant: T32AI083203

National Institute of Allergy and Infectious Diseases

Grant: DP1AI158186

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201700059C

Pew Charitable Trusts

Grant: Biomedical Scholars Award

Burroughs Wellcome Fund

Grant: Investigators in the Pathogenesis of Infectious Disease Awards

Bill and Melinda Gates Foundation

Grant: INV-004949

Bill and Melinda Gates Foundation

Grant: INV-016575

Bill and Melinda Gates Foundation

Grant: OPP1156262

Bill and Melinda Gates Foundation

Grant: INV-018944

National Institutes of Health

Grant: S10OD028685

Damon Runyon Cancer Research Foundation

Grant: DRG-2381-19

National Institutes of Health

Grant: 1S10RR013039-01

MICROPLATE SCINTILLATION/LUMINESCENCE/FLOUR COUNTER

National Institutes of Health

Grant: 1S10OD028685-01

High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases Research

National Institutes of Health

Grant: 5R01AI141707-02

Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins

National Institutes of Health

Grant: 1T32AI083203-01

Viral Pathogenesis Training Program

National Institutes of Health

Grant: 5DP1AI158186-05

Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics

Emergent Ventures Award

Wellcome Trust

Howard Hughes Medical Institute

FWCI

6.96

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.ppat.1010248

publisherhttps://doi.org/10.1371/journal.ppat.1010248

publisherhttps://dx.plos.org/10.1371/journal.ppat.1010248

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35134084

repositoryhttps://doaj.org/article/47294b3432084a629a2f2e376fdff936

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAntibodies, MonoclonalAntibodies, ViralAntibody FormationEpitopesHumansImmunization, PassiveNeutralization TestsAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

ImmunodominancePolyclonal antibodiesEpitopeAntibodyVirologyBiologyNeutralizationImmunologyQH301-705.5SARS-CoV-2Immunization, PassiveAntibodies, MonoclonalCOVID-19RC581-607Antibodies, ViralAntibodies, NeutralizingArticleCOVID-19 Drug TreatmentEpitopesNeutralization TestsAntibody FormationSpike Glycoprotein, CoronavirusHumansImmunologic diseases. AllergyBiology (General)Research Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (10)

A pneumonia outbreak associated with a new coronavirus of probable bat origin

N/A

1.5DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2012-7

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

N/A

1.4DataRank · unranked

New England Journal of Medicine(2020)

co-cited

10.1056/nejmoa2034577

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

N/A

1.4DataRank · unranked

Cell(2020)

co-cited

10.1016/j.cell.2020.02.058

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

N/A

1.4DataRank · unranked

New England Journal of Medicine(2021)

co-cited

10.1056/nejmoa2035389

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

N/A

1.1DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2456-9

Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins

N/A

1.1DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2169-0

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

N/A

16.3DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2852-1

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

N/A

12.4DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2622-0

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

N/A

9.3DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2639-4

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

N/A

1.1DataRank · unranked

Science(2020)

co-cited

10.1126/science.abd0826